Home > Category > Signaling Pathways > Immunology & Inflammation > CTLA-4 > Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)

Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)

ChemLeader 95+%

Catalog No：CLA1678 CAS No.：2329669-78-3 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible.

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)
CAS	2329669-78-3
Storage condition	-80°C for one-year storage.Avoid repeated freeze-thaw.

Product details

Bavunalimab is a bispecific human monoclonal antibody targeting CTLA-4 and LAG-3, it activates T cells in NSG mice. Bavunalimab can be used for the research of cancer.

Related literature

Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents.

PMID: 36399656 DOI: 10.1080/17460441.2022.2148652

Sorry, no related items

History

CLA1678

Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)

2329669-78-3 95+%